摘要
目的探究应用地塞米松与自体血循管预防首次使用综合征的临床疗效。方法选取近3年在我院接受血液透析治疗并发生首次使用综合征的患者360例,将其随机分为地塞米松组、自体血循管组,平均每组180例,地塞米松组患者应用地塞米松进行预充处理,自体血循管组患者采用自体血循管进行预充处理,观察并比较两组患者预防首次使用综合征发生的有效率。结果自体血循管组预充处理后的有效率(99.44%)明显高于地塞米松组预充处理后的有效率(73.33%),两组有显著性差异,统计学上有意义(P<0.05)。结论地塞米松与自体血循管在预防首次使用综合征中,自体血循管有更好的疗效,值得临床应用推广。
Objective To explore the application of dexamethasone and autologous bulky tube preventing first use syndrome clinical effect. Methods Nearly three years in our hospital and patients receiving hemodialysis treatment 360 cases for the first time syndrome occurs randomly divided into conventional group, dexamethasone group, autologous bulky tube group, an average of 120 people in each group, the conventional routine treatment of patients, dexamethasone-treated patients in the dexamethasone group, autologous bulky tube group treated with autologous bulky canal therapy, observed and compared three groups of patients first use syndrome prevention effectiveness. Results The efficiency of dexamethasone group after treatment （98.33%）, as well as the efficiency of bulky tube after autologous treatment group （99.17%） was significantly higher than the conventional treatment group, there are efficiency （49.17%）, dexamethasone group autologous bulky tube group were compared with the conventional group had significant difference statistically significant. Conclusion Dexamethasone and autologous bulky tube preventing first use syndrome, has a good effect, worthy of clinical application of the promotion.
出处
《中国医药指南》
2014年第32期10-11,共2页
Guide of China Medicine
关键词
地塞米松
自体血循管
首次使用综合征
预防
Dexamethasone
Autologous bulky tube
First use syndrome
Prevention
